Scientific Research: Ivermectin and mebendazole – Touted as horse paste during the pandemic, now shown 84% benefit in cancer.

Ivermectin was first discovered in the 1975, it was used only on animals because it kills some internal and external parasites that affect livestock as well as companion animals such as horses and dogs. It was approved for human use in 1987, and in 2015, it won the Nobel Prize for Physiology or Medicine. Since then over 4 billion doses have been dispensed for human consumption.

During the Covid-19 pandemic, the early use of Ivermectin showed it did help combat the coronavirus but Dr. Anthony Fauci wanted to bring in Remdesivir, his failed experimental drug which caused patients to die from liver failure. In order to bring in Remdesivir as an emergency use authorization, there must not be any available medicine to treat the Covid virus. So Ivermectin was crucified in the media and government health directors, and doctors and physicians were banned from using it to treat Covid-19 in many Western countries such as United States and Canada. People with severe Covid symptoms who were admitted to the hospitals were treated with Remdesivir and put on ventilators were more likely to die from liver failure rather than from the Covid virus.

As more people started using Ivermectin, purchased from overseas, to treat Covid, it also had a positive benefit in cancer, even in stage four. Word of mouth gained traction online, these anecdotal testimonies fuelled more people to take a chance on Ivermectin which is paired with mebendazole or fenbendazole to treat their cancers. The result is this proper scientific research study on this Ivermectin and mebendazole pairing as a form of cancer treatment.

This research of Ivermectin and mebendazole combination have shown to have a 84% benefit in cancer treatment, thus demonstrated highly promising multi-target anti-cancer activity. This pairing selectively target cancer stem cells.

More in the Dr. John Campbell video.